Table 5.
Treatment and prognosis of primary epididymal adenocarcinoma reported in the literatures from 2007 to 2017.
| Ref. | Primary treatment | IFP | Interval time※ | Secondary treatment | Follow-up time and prognosis |
|---|---|---|---|---|---|
| Graham et al. 2017 [6] | Epididymectomy, RO, scrotectomy, resection of the inguinal mass and ILND | No use | — | — | 12 mo; right ILN and suspected pulmonary metastasis |
|
| |||||
| Pindoria et al. 2016 [7] | A biopsy | No use | After having a child by IVF treatment | RO and onco-micro TeSE | — |
|
| |||||
| Urabe et al. 2016 [13] |
RO | No use | — | — | 10 mo; no evidence of metastasis and recurrence |
|
| |||||
| Gupta et al. 2015 [8] |
RO | No use | 2 yr | Chemotherapy (capecitabine) | 30 mo; bilateral pulmonary metastasis was found 2 yr after surgery and the lesions were stable 6 mo later |
|
| |||||
| Nozawa et al. 2014 [5] | RO | — | — | — | — |
|
| |||||
| Staník et al. 2012 [9] |
RO | No use | 4 mo | RPLND and chemotherapy (paclitaxel and carboplatin) | 20 mo; no evidence of metastasis and recurrence |
|
| |||||
| Soumarová et al. 2012 [10] | Orchiectomy, RPLND | — | 6 mo | Palliative RT | 48 mo; scrotal recurrence was found 6 mo after surgery and the lesion was complete remission 42 mo after RT |
|
| |||||
| Yang et al. 2010 [15] |
RO, RPLND | Yes | — | — | At least 10 mo; no evidence of metastasis and recurrence |
|
| |||||
| Arisan et al. 2004 [14] | RO, unilateral ILND and chemotherapy (cisplatin and etoposide) | No use | — | — | Patient died of right lateral acetabulum and spleen and liver metastasis after 6 mo |
|
| |||||
| Hayashi et al. 2003 [16] | RO | No use | — | — | 17 mo; no evidence of metastasis and recurrence. |
|
| |||||
| Chauhan et al. 2001 [11] | RO | Yes | 1 yr | RPLND and radiochemotherapy (2nd); palliative chemotherapy (3rd) | Patient died after 30 mo. RLN metastasis occurred 1 yr after initial surgery. Multiple bone metastasis occurred 1 yr after secondary treatment |
|
| |||||
| Ganem et al. 1998 [3] | Transscrotal epididymectomy | No use | 1 mo | Radical orchiectomy and hemiscrotectomy | 18 mo; no evidence of metastasis and recurrence. |
|
| |||||
| Jones et al. 1997 [4] |
①RO ②RO and RT ③RO ④RO, RPLND and ILND |
①No use ②No use ③No use ④No use |
① 1 yr ② — ③ — ④ — |
① RPLND ② — ③ — ④ — |
① Patient died after 20 mo. RLN metastasis occurred 1 yr after initial surgery. Bilateral lung metastasis occurred 8 mo later. ② Patient died of extensive abdominal and PLN metastases after 6 mo. ③ — ④ 30 yr; no evidence of metastasis and recurrence |
IFP: intraoperative frozen pathology; ILN: inguinal lymph node; ILND: inguinal lymph node dissection; IVF: in vitro fertilization; onco-micro TeSE: microsurgical testicular sperm extraction in cancer patients; PLN: pelvic lymph node; RPLN: retroperitoneal lymph node; RPLND: retroperitoneal lymph node dissection; RO: radical orchiectomy; RT: radiotherapy. ※interval time indicates the time between primary and secondary treatment.